NCT03958955: A reported trial by LEO Pharma
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03958955 |
|---|---|
| Title | Efficacy and Safety of Twice-daily Application of Delgocitinib Cream 20 mg/g for 6 Weeks in Subjects With Active Discoid Lupus Erythematosus. |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 9, 2019 |
| Completion date | April 15, 2020 |
| Required reporting date | April 15, 2021, midnight |
| Actual reporting date | April 14, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |